Cyclo Therapeutics Inc (CYTH)

[John Bates]

Yeah, I know what you're talking about. I don't know, but I did find the technical talk that followed a bit encouraging. I got a sense that sales might get a boost in a quarter or two, but who knows. Thing is, they don't really have to do that much with their margins to start bringing in a respectable EPS and a 20-30 cent stock price. They just have to make something happen to reach the next level.